NO20032315L - 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer - Google Patents
4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorerInfo
- Publication number
- NO20032315L NO20032315L NO20032315A NO20032315A NO20032315L NO 20032315 L NO20032315 L NO 20032315L NO 20032315 A NO20032315 A NO 20032315A NO 20032315 A NO20032315 A NO 20032315A NO 20032315 L NO20032315 L NO 20032315L
- Authority
- NO
- Norway
- Prior art keywords
- biphenylcarbonylamino
- piperidine derivatives
- mtp inhibitors
- mtp
- inhibitors
- Prior art date
Links
- UGTSHKSSLJCDTJ-UHFFFAOYSA-N 2-phenyl-n-piperidin-4-ylbenzamide Chemical class C=1C=CC=C(C=2C=CC=CC=2)C=1C(=O)NC1CCNCC1 UGTSHKSSLJCDTJ-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0015143A FR2816940A1 (fr) | 2000-11-23 | 2000-11-23 | Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation |
| PCT/EP2001/012326 WO2002042291A1 (en) | 2000-11-23 | 2001-10-25 | 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032315D0 NO20032315D0 (no) | 2003-05-22 |
| NO20032315L true NO20032315L (no) | 2003-05-22 |
Family
ID=8856805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032315A NO20032315L (no) | 2000-11-23 | 2003-05-22 | 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20040034028A1 (sk) |
| EP (1) | EP1335912A1 (sk) |
| JP (1) | JP2004514676A (sk) |
| KR (1) | KR20030060954A (sk) |
| CN (1) | CN1476445A (sk) |
| AR (1) | AR031499A1 (sk) |
| AU (1) | AU2002221745A1 (sk) |
| BR (1) | BR0115520A (sk) |
| CA (1) | CA2429326A1 (sk) |
| CZ (1) | CZ20031619A3 (sk) |
| FR (1) | FR2816940A1 (sk) |
| HU (1) | HUP0400819A2 (sk) |
| IL (1) | IL155986A0 (sk) |
| MX (1) | MXPA03004540A (sk) |
| NO (1) | NO20032315L (sk) |
| PE (1) | PE20020595A1 (sk) |
| PL (1) | PL365939A1 (sk) |
| RU (1) | RU2003117458A (sk) |
| SK (1) | SK7362003A3 (sk) |
| WO (1) | WO2002042291A1 (sk) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1404653T1 (sl) | 2001-06-28 | 2008-12-31 | Pfizer Prod Inc | S triamidom substituirani indoli, benzofurani in benzotiofeni kot zaviralci mikrosomske prenašalnebeljakovine za trigliceride (MTP) in/ali izločanja apolipoproteina B (APO B) |
| CN101838218A (zh) | 2002-02-28 | 2010-09-22 | 日本烟草产业株式会社 | 酯化合物及其医药用途 |
| FR2856685B1 (fr) * | 2003-06-25 | 2005-09-23 | Merck Sante Sas | Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2005021486A1 (ja) | 2003-08-29 | 2005-03-10 | Japan Tobacco Inc. | エステル誘導体及びその医薬用途 |
| FR2865733B1 (fr) * | 2004-02-04 | 2007-10-12 | Merck Sante Sas | Derives de thiazolylimidazole, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en medecine |
| FR2871463B1 (fr) * | 2004-06-11 | 2006-09-22 | Merck Sante Soc Par Actions Si | Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique |
| US8101774B2 (en) | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
| FR2884831B1 (fr) * | 2005-04-22 | 2007-08-10 | Merck Sante Soc Par Actions Si | Methode de criblage de composes inhibiteurs de la mtp |
| JP5525261B2 (ja) | 2006-10-24 | 2014-06-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｍｔｐ阻害性テトラヒドロ−ナフタレン−１−カルボン酸誘導体 |
| JO2653B1 (en) * | 2006-10-24 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Tetrahydroflavin 1-carboxylic acid substituted with pyridine or pyrazine inhibit MTB |
| MX2009006543A (es) * | 2006-12-20 | 2009-06-26 | Amgen Inc | Compuestos heterociclicos y su uso en el tratamiento de la inflamacion, angiogenesis y cancer. |
| AR074466A1 (es) | 2008-12-05 | 2011-01-19 | Sanofi Aventis | Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3. |
| KR101650981B1 (ko) | 2009-09-03 | 2016-08-24 | 바이오에너제닉스 | Ｐａｓｋ의 억제를 위한 복소환 화합물 |
| JP5980812B2 (ja) | 2011-01-05 | 2016-08-31 | バイオエナジェニックス | Ｐａｓｋの阻害のための複素環化合物 |
| US8916561B2 (en) | 2011-03-02 | 2014-12-23 | Bioenergenix, Llc | Substituted quinoxaline compounds for the inhibition of PASK |
| EP2681207B1 (en) | 2011-03-02 | 2016-12-28 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
| JP6664632B2 (ja) * | 2013-09-30 | 2020-03-13 | 国立大学法人 東京大学 | アディポネクチン受容体活性化化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8528234D0 (en) * | 1985-11-15 | 1985-12-18 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| US5595872A (en) * | 1992-03-06 | 1997-01-21 | Bristol-Myers Squibb Company | Nucleic acids encoding microsomal trigyceride transfer protein |
| CA2123728A1 (en) * | 1993-05-21 | 1994-11-22 | Noriyoshi Sueda | Urea derivatives and their use as acat inhibitors |
| WO1997013766A1 (en) * | 1995-10-13 | 1997-04-17 | Banyu Pharmaceutical Co., Ltd. | Substituted heteroaromatic derivatives |
| WO1997045414A1 (en) * | 1996-05-31 | 1997-12-04 | Banyu Pharmaceutical Co., Ltd. | 1,4-disubstituted piperidine derivatives |
-
2000
- 2000-11-23 FR FR0015143A patent/FR2816940A1/fr not_active Withdrawn
-
2001
- 2001-10-25 CN CNA018192866A patent/CN1476445A/zh active Pending
- 2001-10-25 RU RU2003117458/04A patent/RU2003117458A/ru not_active Application Discontinuation
- 2001-10-25 CA CA002429326A patent/CA2429326A1/en not_active Abandoned
- 2001-10-25 US US10/432,323 patent/US20040034028A1/en not_active Abandoned
- 2001-10-25 CZ CZ20031619A patent/CZ20031619A3/cs unknown
- 2001-10-25 PL PL01365939A patent/PL365939A1/xx unknown
- 2001-10-25 IL IL15598601A patent/IL155986A0/xx unknown
- 2001-10-25 JP JP2002544425A patent/JP2004514676A/ja active Pending
- 2001-10-25 SK SK736-2003A patent/SK7362003A3/sk unknown
- 2001-10-25 BR BR0115520-2A patent/BR0115520A/pt not_active Application Discontinuation
- 2001-10-25 MX MXPA03004540A patent/MXPA03004540A/es unknown
- 2001-10-25 WO PCT/EP2001/012326 patent/WO2002042291A1/en not_active Ceased
- 2001-10-25 AU AU2002221745A patent/AU2002221745A1/en not_active Abandoned
- 2001-10-25 EP EP01997486A patent/EP1335912A1/en not_active Withdrawn
- 2001-10-25 KR KR10-2003-7006923A patent/KR20030060954A/ko not_active Withdrawn
- 2001-10-25 HU HU0400819A patent/HUP0400819A2/hu unknown
- 2001-11-23 AR ARP010105460A patent/AR031499A1/es unknown
- 2001-11-23 PE PE2001001175A patent/PE20020595A1/es not_active Application Discontinuation
-
2003
- 2003-05-22 NO NO20032315A patent/NO20032315L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004514676A (ja) | 2004-05-20 |
| CN1476445A (zh) | 2004-02-18 |
| PL365939A1 (en) | 2005-01-24 |
| BR0115520A (pt) | 2003-09-16 |
| NO20032315D0 (no) | 2003-05-22 |
| HUP0400819A2 (hu) | 2004-07-28 |
| AR031499A1 (es) | 2003-09-24 |
| PE20020595A1 (es) | 2002-07-08 |
| FR2816940A1 (fr) | 2002-05-24 |
| AU2002221745A1 (en) | 2002-06-03 |
| MXPA03004540A (es) | 2003-09-10 |
| US20040034028A1 (en) | 2004-02-19 |
| SK7362003A3 (en) | 2003-11-04 |
| IL155986A0 (en) | 2003-12-23 |
| RU2003117458A (ru) | 2004-12-27 |
| WO2002042291A1 (en) | 2002-05-30 |
| CA2429326A1 (en) | 2002-05-30 |
| KR20030060954A (ko) | 2003-07-16 |
| EP1335912A1 (en) | 2003-08-20 |
| CZ20031619A3 (cs) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE437862T1 (de) | Pyrimidin-5-onderivate als ldl-pla2 inhibitoren | |
| NO20030055L (no) | Colchinolderivater som angiogenese inhibitorer | |
| NO20030135D0 (no) | Piperidinforbindelser for bruk som CCR-3 inhibitorer | |
| DK1515969T3 (da) | Spiroindolinpiperidinderivater | |
| NO20026125L (no) | Tetrahydropyridin- eller piperidin-heterocykliske derivater | |
| DE60211317D1 (de) | Rho-kinase inhibitoren | |
| DE60218138D1 (de) | Rho-kinase inhibitoren | |
| DK1326858T3 (da) | Piperidinforbindelser som anti-allergiske midler | |
| NO20030867D0 (no) | Hydroksamderivater anvendelig som deacetylaseinhibitorer | |
| NO20021239L (no) | Pteridinoner som kinase-inhibitorer | |
| ATE441631T1 (de) | Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer | |
| DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
| ATE524441T1 (de) | Vla-4-inhibitoren | |
| DK1460066T3 (da) | Piperazinforbindelse som tachykinin-inhibitorer | |
| NO20014642L (no) | Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer | |
| ATE370137T1 (de) | 4-(6-gliedriger)-heteroaryl-acyl-pyrrolidin derivate als hcv-inhibitoren | |
| DE60320933D1 (de) | Rho-kinase inhibitoren | |
| DK1650203T3 (da) | Quinolinonderivater som tyrosinkinaseinhibitorer | |
| NO20034308L (no) | Nye tyrokinase-inhibitorer | |
| NO20032315D0 (no) | 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer | |
| ATE308543T1 (de) | Piperidinderivate | |
| NO20024997D0 (no) | 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer | |
| DK1360184T3 (da) | Piperidinderivater som neurokinin-1-antagonister | |
| NO20035440D0 (no) | Pyrrolidinderivater som faktor-XA-inhibitorer | |
| NO20032807D0 (no) | Substituerte 8-arylkinolin-fosfodiesterase-4-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |